4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2018 / Systematic review
A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.
van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436
2017 / Meta-analysis of randomized controlled trials
A meta-analysis of 6 randomized controlled trials with 204 participants examined blueberry supplementation. The intervention showed no significant effect on systolic blood pressure (mean difference -0.28 mmHg, 95% CI: -1.11 to 0.56) or diastolic blood pressure (mean difference -0.5 mmHg, 95% CI: -1.24 to 0.24). Overall, findings did not demonstrate clinical efficacy for improving blood pressure.
Zhu Y, Sun J, Lu W, et al. J Hum Hypertens, 2017. PMID 27654329
2015 / Randomized controlled trial
In an eight-week trial, 48 postmenopausal women with pre- and stage 1-hypertension received 22 g daily of freeze-dried blueberry powder or control powder. Systolic blood pressure (131±17 mm Hg, P<0.05), diastolic blood pressure (75±9 mm Hg, P<0.01), and brachial-ankle pulse wave velocity (1,401±122 cm/second, P<0.01) decreased significantly from baseline in the blueberry group, along with increased nitric oxide levels (15.35±11.16 μmol/L, P<0.01). No changes occurred in the control powder group.
Johnson SA, Figueroa A, Navaei N, et al. J Acad Nutr Diet, 2015. PMID 25578927
2014 / Randomized controlled trial
A randomized trial tested daily blueberry powder against placebo for 6 weeks in 25 men and postmenopausal women aged 18 to 50 years. Blueberry intake decreased augmentation index (P = .024) and aortic systolic pressure (P = .046) and increased absolute natural killer cell counts (interaction P = .012). Body mass, overall blood pressure, and plasma redox were unchanged, though a prehypertensive subset (n = 9) showed reduced diastolic pressure (P = .038).
McAnulty LS, Collier SR, Landram MJ, et al. Nutr Res, 2014. PMID 25150116
2014 / Randomized crossover trial
Sixteen male smokers underwent three crossover sessions examining one cigarette alone, one cigarette after consuming 300 g of blueberries, or one cigarette after sugar water. Blueberries counteracted acute smoking-induced declines in reactive hyperemia index (-4.4 ± 0.8% versus -22.0 ± 1.1%, p < 0.01) and Framingham reactive hyperemia (+28.3 ± 19.2% versus -42.8 ± 20.0%, p < 0.0001). The fruit also blunted the smoking-related spike in systolic blood pressure (+8.4 ± 0.02% versus +13.1 ± 0.02%, p < 0.05), but did not modify arterial stiffness.
Del Bo' C, Porrini M, Fracassetti D, et al. Food Funct, 2014. PMID 25263326
2010 / Randomized controlled trial
A randomized controlled trial evaluated 48 obese individuals with metabolic syndrome consuming either a freeze-dried blueberry beverage (equal to approximately 350 g fresh fruit) or water daily for 8 weeks. Systolic and diastolic blood pressure decreased more with blueberries (-6% and -4%) than control fluids (-1.5% and -1.2%, P < 0.05). Plasma oxidized LDL fell more in the blueberry group (-28% vs -9%, P < 0.01), while glucose and lipid profiles remained unaffected.
Basu A, Du M, Leyva MJ, et al. J Nutr, 2010. PMID 20660279
2011 / Prospective cohort study
Researchers evaluated the relationship between habitual flavonoid intake and incident hypertension among 87,242 women from NHS II, 46,672 women from NHS I, and 23,043 men from HPFS over 14 years of follow-up. During follow-up, 29,018 hypertension cases in women and 5,629 in men were reported. In pooled multivariate-adjusted analyses, participants in the highest quintile of anthocyanin intake had an 8% lower risk of hypertension (RR: 0.92; 95% CI: 0.86, 0.98; P < 0.03) compared with the lowest quintile, with a 12% lower risk in participants aged ≤60 years (RR: 0.88; 95% CI: 0.84, 0.93; P < 0.001). Highest intake of apigenin was linked to a 5% risk reduction (95% CI: 0.91, 0.99; P = 0.005), and catechin intake was linked to a 6% lower risk (95% CI: 0.88, 0.97; P = 0.002) in those aged ≤60 years.
Shows an association, not proof of cause and effect.
Cassidy A, O'Reilly ÉJ, Kay C, et al. Am J Clin Nutr, 2011. PMID 21106916